Jayne Juvan and Dan McClain of Tucker Ellis LLP discuss the slowdown in M&A transactions, in light of the rollout of tariffs, and ways to bridge the gap through contingent consideration where some of ...

In mergers and acquisitions, CFOs must identify whether payments are contingent consideration or postacquisition compensation ...

Following a review process conducted with the assistance of its legal and financial advisors, the Kronos Bio Board of ...

LENSAR is being acquired by Alcon for $14 per share, with an additional CVR offering up to $2.75 based on future procedure targets. The CVR offers potential 20% returns over 2.5 years, translating ...

each pursuant to the contingent value rights agreement (the “CVR Agreement”). Following a review process conducted with the assistance of its legal and financial advisors, the Kronos Bio Board ...

Novartis Acquires Regulus Therapeutics in $1.7 Billion Deal for ADPKD Treatment ...

Novartis to buy Regulus for $0.8 billion upfront with potential for $1.7B total based on ADPKD drug milestone; deal set to ...

Stockholders are being offered an upfront payment of $3.00 per share in cash, plus a contingent value right (CVR) of $6.84 per share in cash, which is payable upon the achievement of a specific ...

and One contingent value right (each, a "CVR"), which is contingent on the sale of Till’s 33.3% ownership of IG Far East LLC (the "Contingent Event"), which will be eligible to convert into an ...